Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Hepatology Communications
|
May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Nature Communications
|
November 12, 2021
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells
W Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, et al.
Scientific Reports
|
January 31, 2019
A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations
Allison M L Nixon, Alejandro Duque, Nicholas Yelle, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 11, 2020
Authors' Response
Barry A Finette, Megan McLaughlin, Samuel V Scarpino, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Development and Initial Validation of a Frontline Health Worker mHealth Assessment Platform (MEDSINC<sup>®</sup>) for Children 2-60 Months of Age
Barry A Finette, Megan McLaughlin, Samuel V Scarpino, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
Kurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Molecular Cancer Therapeutics
|
November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies
Ekta Patel, Natalia V Malkova, David Crowe, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Hepatology Communications
|
May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Nature Communications
|
November 12, 2021
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells
W Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, et al.
Scientific Reports
|
January 31, 2019
A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations
Allison M L Nixon, Alejandro Duque, Nicholas Yelle, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 11, 2020
Authors' Response
Barry A Finette, Megan McLaughlin, Samuel V Scarpino, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Development and Initial Validation of a Frontline Health Worker mHealth Assessment Platform (MEDSINC<sup>®</sup>) for Children 2-60 Months of Age
Barry A Finette, Megan McLaughlin, Samuel V Scarpino, et al.
Journal for Immunotherapy of Cancer
|
January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
Kurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Molecular Cancer Therapeutics
|
November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies
Ekta Patel, Natalia V Malkova, David Crowe, et al.
Page
of 3